Jim Potenziano

Opinion author

Jim Potenziano, PhD, is the vice president, Medical Affairs at Tris Pharma. He has over 25 years of experience in pharmaceutical and biotech leading medical and R&D organizations, where he’s led the development and launch of several new drugs and devices. Potenziano holds a PhD from The State University of New York Binghamton and completed a postdoctoral fellowship from the National Institutes of Health.

Alternatives to opioids are desperately needed to better treat moderate to severe acute pain, but to date, we’ve seen few novel analgesics hit the market.